Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Year range
1.
Acta cir. bras ; 34(2): e201900204, 2019. tab, graf
Article in English | LILACS | ID: biblio-989051

ABSTRACT

Abstract Purpose: To investigate the protective effects of salvianolic acid A (SAA) on renal damage in rats with chronic renal failure (CRF). Methods: The five-sixth nephrectomy model of CRF was successfully established in group CRF (10 rats) and group CRF+SAA (10 rats). Ten rats were selected as sham-operated group (group S), in which only the capsules of both kidneys were removed. The rats in group CRF+SAA were intragastrically administrated with 10 mg/kg SAA for 8 weeks. The blood urine nitrogen (BUN), urine creatinine (Ucr), creatinine clearance rate (Ccr), and serum uperoxide dismutase (SOD) and malondialdehyde (MDA) were tested. The expressions of transforming growth factor-β1 (TGF-β1), bone morphogenetic protein 7 (BMP-7) and Smad6 protein in renal tissue were determined. Results: After treatment, compared with group CRF, in group CRF+SAA the BUN, Scr, serum MDA and kidney/body weight ratio were decreased, the Ccr and serum SOD were increased, the TGF-β1 protein expression level in renal tissue was decreased, and the BMP-7 and Smad6 protein levels were increased (all P < 0.05). Conclusion: SAA can alleviate the renal damage in CRF rats through anti-oxidant stress, down-regulation of TGF-β1 signaling pathway and up-regulation of BMP-7/Smad6 signaling pathway.


Subject(s)
Animals , Male , Rats , Caffeic Acids/therapeutic use , Smad6 Protein/metabolism , Transforming Growth Factor beta1/metabolism , Bone Morphogenetic Protein 7/metabolism , Kidney Failure, Chronic/drug therapy , Lactates/therapeutic use , Down-Regulation , Up-Regulation , Rats, Sprague-Dawley , Disease Models, Animal , Kidney Failure, Chronic/chemically induced , Kidney Failure, Chronic/metabolism , Kidney Function Tests , Nephrectomy
2.
Rio de Janeiro; s.n; 2012. 75 p. ilus.
Thesis in Portuguese | LILACS | ID: lil-691811

ABSTRACT

Numerosos modelos in vitro e in vivo foram desenvolvidos para estudar o reparo de lesões e identificar os mecanismos chave deste processo. Visando avaliar o processo de cicatrização utilizamos um modelo de lesão excisional total e um modelo de queimadura promovida por escaldamento. No estudo utilizando o modelo de lesão excisional total, abordamos o uso da aspirina (um inibidor não seletivo da COX) e seu efeito diferenciado sobre os sexos na cicatrização cutânea de camundongos. Observamos que os grupos fêmea controle e tratado apresentaram contração atrasada comparado aos grupos macho controle e tratado, respectivamente. Entre os grupos fêmea e macho controles, as fêmeas apresentaram menor atividade da mieloperoxidase e menor quantidade de células MIF-positivas do que os machos controle. Já entre os grupos fêmea e macho tratados, foi observado que nas fêmeas tratadas, a atividade da mieloperoxidase e a quantidade de macrófagos F4/80-positivos estavam maiores do que no grupo macho tratado. Ainda entre os grupos tratados, as fêmeas apresentaram menores níveis de hidroxiprolina e maior expressão proteica de vWF e VEGF comparado aos machos. No estudo das lesões causadas por queimadura, avaliamos as propriedades anti- inflamatórias e antioxidantes do ácido cafeico fenetil ester (CAPE) no reparo destas lesões e observamos que em 7, 14, 21 e 70 dias após a queimadura, o grupo queimado+CAPE apresentou menor área lesada, além de menor atividade da mieloperoxidase e dos níveis de nitrito do que o grupo queimado. Também foi observado que no grupo queimado+CAPE a expressão proteica de CD68 e de PECAM-1 estava reduzida comparada ao grupo queimado. Analisando os parâmetros de dano oxidativo foi observado que os níveis de MDA e de proteínas carboniladas estavam menores no grupo queimado+CAPE do que no grupo queimado, tanto no plasma quanto na lesão. Em suma, nosso estudo avaliou o processo de cicatrização de dois modelos de lesão, em roedores de diferentes espécies ...


Several in vitro and in vivo models have been developed to study wound healing and to identify key mechanisms of this process. The most of these studies use animals models to reproduce the human physiology and possible therapeutic treatments. In order to evaluate the wound healing process in different wound models, we use a full-thickness excisional wound model and a burn model promoted by scalding. In the full-thickness excisional wound study, we approach the aspirin use (COX non-selective inhibitor) and its distinct effect on the gender in cutaneous wound healing on mice. It was observed that both female control and treated groups presented smaller wound area than male control and treated groups, respectively. Between female and male control groups, the females presented smaller myeloperoxidase activity and MIF-positive cells than control males. Comparing female and male treated groups it was observed that in female treated group, the myeloperoxidase activity and the F4/80-positive macrophages amount were greater than male treated group. Also between the treated groups, the females presented smaller hydroxyproline levels and greater vWF and VEGF protein expression compared to the males. In study of the burns performed by scalding, it was evaluated the caffeic acid phenethyl ester (CAPE) anti-inflammatory and antioxidant properties on repair of these lesions. It was observed that at 7, 14, 21 and 70 days after burning, the burn+CAPE group presented smaller wound area, beyond smaller myeloperoxidase activity and nitrite levels than burn group. It was also observed that the burn+CAPE group presented smaller CD68 and PECAM-1 protein expression compared to burn group. Analyzing the oxidative damage parameters, it was observed that the MDA and carbonilated proteins levels were greater in the burn group compared to burn+CAPE group. In conclusion, our study evaluated the wound healing process in 2 wound models on distinct rodent species with distinct approaches ...


Subject(s)
Animals , Mice , Aspirin/therapeutic use , Wound Healing , Skin/injuries , Caffeic Acids/pharmacology , Caffeic Acids/therapeutic use , Phenylethyl Alcohol/analogs & derivatives , Wounds and Injuries/drug therapy , Granulation Tissue , Burns/drug therapy , Sex Factors
3.
Braz. j. infect. dis ; 15(4): 332-338, July-Aug. 2011. ilus, tab
Article in English | LILACS | ID: lil-595674

ABSTRACT

BACKGROUND: Severe pathogenic infection triggers excessive release of cytokines as part of the massive inflammatory response associated with septic shock. OBJECTIVES: To investigate the protective effect of caffeic acid phenethye ester (CAPE) against lipopolysaccharide (LPS) induced endotoxemia, hepatic and neuronal damage and the associated systemic inflammatory response (SIR). METHODS: Fifty male Wister rats were divided into: control, LPS, and CAPE+LPS groups. Plasma concentrations of various cytokines, including TNF-α, IL-1α, IL-1β, IL-6, IL-4, IL-10, and sICAM-1 were evaluated. In addition, the histopathological changes in the hepatic and neural cells were assessed. RESULTS: The LPS group showed high inflammatory cytokines and sICAM-1 levels reflecting the presence of SIR. Hepatocyte necrosis, apoptosis, extensive hemorrhage and inflammatory cellular infiltration together with brain astrocytes swelling, early neuron injury and presence of inflammatory foci confirmed the toxic tissue damage. Use of CAPE decreased the inflammatory cytokines and increased the anti-inflammatory cytokines levels. This biochemical evidence of decreased SIR was confirmed histologically by decreased cellular infiltration in the liver and brain tissue which coincides with preserved structure and protection of the liver and brain cells from the toxic effects of LPS. CONCLUSION: The ability of CAPE to alleviate the SIR, hepatic and neuronal cell damage induced by LPS and galactosamine could be attributed to its ability to reverse the imbalance of the pro- and anti-inflammatory cytokines which may lead to the inhibition of adhesion molecules' expression. CAPE is a promising agent that could help in the prophylaxis and treatment of septic shock.


Subject(s)
Animals , Male , Rats , Brain/pathology , Caffeic Acids/therapeutic use , Cytokines/blood , Endotoxemia/prevention & control , Liver/pathology , Phenylethyl Alcohol/analogs & derivatives , Shock, Septic/prevention & control , Systemic Inflammatory Response Syndrome/prevention & control , Brain/drug effects , Endotoxemia/blood , Endotoxemia/chemically induced , Galactosamine/pharmacology , Lipopolysaccharides/pharmacology , Liver/drug effects , Phenylethyl Alcohol/therapeutic use , Rats, Wistar , Shock, Septic/blood , Shock, Septic/chemically induced , Shock, Septic/pathology , Systemic Inflammatory Response Syndrome/blood
5.
Rev. mex. ortop. traumatol ; 6(4): 104-7, jul.-ago. 1992. ilus, tab
Article in Spanish | LILACS | ID: lil-117884

ABSTRACT

La fisiopatología del síndrome de embolia grasa (SEG) se ha asociado a diferentes mediadores proinflamatorios. En este trabajo se postula la participación del tromboxaqno A2 (TxA2) y de los leucotrienos (Lts). Se desarrolló un modelo experimental de embolismo graso en el mediante la fractura del emur y la administración de médula ósea autóloga. Se midieron la presión arterial media (PAM), la presión venosa central (PVC), la sobrevida y los gases arteriales en cuatro grupos (n=7) que recibieron los siguientes tratamientos; una hora antes del embolismo: grupo 1, sin tratamiento; grupo 2, bicarbonato de sodio al 3 por ciento; grupo 3, ácido acetilsalicílico (AAS) como inhibidor de la síntesis TxA2 (10mg/Kg) y grupo 4, ácido cafeico como inhibridor de la síntesis de Lts (15 mg/Kg). En todos los casos se demostraron los signos histopatológicos, los cambios en las presiones y la gasometria, compatibles con embolismo graso. El AAS y el ácido cafeico brindaron protección parcial (en el cambio en la presión venosa central y en la sobrevida). El AAS disminuyó además, los cambios en la gasometría. Se concluye que el TxA2 y los Lts. entre otros medidores participan en el modelo utilizado, el cual reproduce el embolismo grado humano y podría ser utilizado como prueba de cernimientos de las drogas con potencial terapéutico en el SEG.


Subject(s)
Animals , Rabbits , Prostaglandin Antagonists/therapeutic use , Rabbits/immunology , Sodium/therapeutic use , Transplantation, Autologous/adverse effects , Bicarbonates/therapeutic use , Prostaglandins , Aspirin/therapeutic use , Leukotrienes , Embolism, Fat/drug therapy , Caffeic Acids/therapeutic use , Femoral Fractures/complications , Bone Marrow
SELECTION OF CITATIONS
SEARCH DETAIL